HCPCS Code Detail Logo

HCPCS Codes Similar to G9197

HCPCS Codes Similar to “G9197” Code.
Documentation of order for first or second generation cephalosporin for antimicrobial prophylaxis

G9196
Documentation of medical reason(s) for not ordering a first or second generation cephalosporin for antimicrobial prophylaxis (e.g., patients enrolled in clinical trials, patients with documented infection prior to surgical procedure of interest, patients who were receiving antibiotics more than 24 hours prior to surgery [except colon surgery patients taking oral prophylactic antibiotics], patients who were receiving antibiotics within 24 hours prior to arrival [except colon surgery patients taking oral prophylactic antibiotics], other medical reason(s))
Code added date: 20140101
Code effective date: 20230101
G9198
Order for first or second generation cephalosporin for antimicrobial prophylaxis was not documented, reason not given
Code added date: 20140101
Code effective date: 20230101
M0236
Intravenous infusion, monoclonal antibody products with an indication for post-exposure prophylaxis or treatment of covid-19, for hospitalized adults and/or pediatric patients who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, not otherwise classified, second dose
Code added date: 20251001
Code effective date: 20251001
G8916
Patient with preoperative order for iv antibiotic surgical site infection (ssi) prophylaxis, antibiotic initiated on time
Code added date: 20120401
Code effective date: 20120401
G8917
Patient with preoperative order for iv antibiotic surgical site infection (ssi) prophylaxis, antibiotic not initiated on time
Code added date: 20120401
Code effective date: 20120401
G8918
Patient without preoperative order for iv antibiotic surgical site infection (ssi) prophylaxis
Code added date: 20120401
Code effective date: 20120401
G9220
Pneumocystis jiroveci pneumonia prophylaxis not prescribed within 3 months of low cd4+ cell count below 500 cells/mm3 or a cd4 percentage below 15% for medical reason (i.e., patient's cd4+ cell count above threshold within 3 months after cd4+ cell count below threshold, indicating that the patient's cd4+ levels are within an acceptable range and the patient does not require pcp prophylaxis)
Code added date: 20140101
Code effective date: 20150101
M1238
Documentation that administration of second recombinant zoster vaccine could not occur during the performance period due to the recommended 2-6 month interval between doses (i.e, first dose received after october 31)
Code added date: 20240101
Code effective date: 20240101
M0235
Intravenous infusion, monoclonal antibody products with an indication for post-exposure prophylaxis or treatment of covid-19, for hospitalized adults and/or pediatric patients who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, not otherwise classified, first dose
Code added date: 20251001
Code effective date: 20251001
M1385
Documentation of patient reasons for patients who were not seen for the second pam survey (e.g., less than four months between baseline pam assessment and follow-up
Code added date: 20250101
Code effective date: 20250101
G8629
Documentation of order for prophylactic parenteral antibiotic to be given within one hour (if fluoroquinolone or vancomycin, two hours) prior to surgical incision (or start of procedure when no incision is required)
Code added date: 20110101
Code effective date: 20150101
G8811
Documentation rh-immunoglobulin (rhogam) was not ordered, reason not given
Code added date: 20120101
Code effective date: 20210101
G9609
Documentation of an order for anti-platelet agents
Code added date: 20160101
Code effective date: 20170101
G9650
Documentation that the patient declined therapy change or has documented contraindications (e.g., experienced adverse effects or lack of efficacy with all other therapy options) in order to achieve better disease control as measured by pga, bsa, pasi, or dlqi
Code added date: 20160101
Code effective date: 20170101